For millions of families worldwide, the loss of loved ones during the pandemic remains an open wound. In the wake of this collective trauma, various narratives have emerged attempting to explain the staggering mortality rates of the early 2020s. Some of these claims suggest that the deaths were not caused by the SARS-CoV-2 virus, but were instead the result of medical interventions—specifically the use of ventilators, the antiviral drug Remdesivir, and palliative medications like Midazolam, and Morphine.
However, a comprehensive review of global clinical data and peer-reviewed research confirms that the accusation that COVID-19 deaths were caused by remdesivir and ventilators is a myth. The overwhelming medical evidence demonstrates that the primary driver of mortality was the virus itself, which triggered systemic organ failure and severe respiratory distress, while the treatments in question were attempts to stabilize or comfort patients in critical condition.
As a physician, I have seen how complex critical care can appear to those outside the intensive care unit (ICU). When a patient dies while connected to a machine or after receiving a specific medication, it is easy to mistake the treatment for the cause of death. In medicine, this is a known cognitive trap. In reality, these interventions were deployed because the patients were already experiencing life-threatening physiological collapse.
The Role of Mechanical Ventilation in Respiratory Failure
One of the most persistent claims is that ventilators “killed” patients. To understand why this is inaccurate, it is necessary to understand Acute Respiratory Distress Syndrome (ARDS), a common and deadly complication of severe COVID-19. In ARDS, the lungs fill with fluid and inflammation, making it impossible for oxygen to reach the bloodstream. At this stage, the patient is effectively suffocating.
Ventilators are not “cures” for the virus; they are life-support tools designed to do the work of the lungs when they can no longer function. While early in the pandemic there was a learning curve regarding the optimal settings for ventilating COVID-19 patients—leading to a shift toward “protective lung ventilation” to avoid lung injury—the machines themselves did not cause the underlying disease. When a patient dies on a ventilator, it is typically because the viral damage to the lungs and the subsequent inflammatory response (often called a cytokine storm) became irreversible.
Data from the World Health Organization has consistently shown that the primary cause of death in severe cases was respiratory failure and multi-organ dysfunction caused by the infection, not the equipment used to treat the symptoms.
Evaluating Remdesivir and Antiviral Therapy
Remdesivir, an antiviral medication, became a focal point for misinformation. Claims that the drug acted as a “poison” are contradicted by large-scale, randomized controlled trials. The goal of Remdesivir was to inhibit the virus’s ability to replicate within the host’s cells, thereby reducing the severity of the illness.
Clinical trials, including those monitored by the National Institutes of Health (NIH), indicated that while Remdesivir may not have significantly reduced the overall mortality rate in every patient subgroup, it did shorten recovery times for many hospitalized patients. There is no verified clinical evidence suggesting that Remdesivir caused the mass mortality attributed to COVID-19. Like all medications, it has potential side effects—such as impacts on kidney or liver function in some patients—but these are monitored closely by physicians and are distinct from the cause of death in viral pneumonia.
Comparison of Treatment Intent vs. Misconception
| Treatment | Misconception | Medical Reality |
|---|---|---|
| Ventilators | Caused death by lung damage | Supported breathing during ARDS/respiratory failure |
| Remdesivir | Acted as a poison to patients | Antiviral designed to stop viral replication |
| Morphine/Midazolam | Used to intentionally end life | Palliative care to relieve “air hunger” and anxiety |
Palliative Care and the Ethics of Comfort
Perhaps the most sensitive claim involves the use of Midazolam (a sedative) and Morphine (an opioid) in the United Kingdom and elsewhere. These medications are staples of palliative care. When a patient reaches the end of life and is experiencing “air hunger”—the terrifying sensation of being unable to breathe—Morphine is the gold standard for reducing the perception of breathlessness and easing distress.
Midazolam is used to treat severe agitation and anxiety, which are common in patients experiencing hypoxic delirium (confusion caused by lack of oxygen to the brain). Using these medications in terminal cases is not “poisoning”; it is the ethical application of comfort care to ensure a patient does not die in a state of panic or physical agony. These drugs are administered when the medical team has determined that the underlying disease—COVID-19—is no longer responsive to curative treatment.
Why This Misinformation Persists
The gap between clinical reality and public perception often stems from the “correlation vs. Causation” fallacy. Because many patients received these treatments shortly before they passed away, some observers concluded that the treatments caused the death. However, the timeline is reversed: the severity of the COVID-19 infection necessitated the treatment.
the sheer scale of the pandemic created a systemic strain on healthcare workers, which sometimes limited the ability to communicate the nuances of end-of-life care to grieving families in real-time. This vacuum of information was often filled by unfounded theories that offered a simpler, though inaccurate, explanation for the loss.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
As public health agencies continue to analyze the long-term data from the pandemic, the focus has shifted toward preventing future outbreaks and managing “Long COVID.” Official reports from national health registries continue to be updated as part of the ongoing global audit of pandemic responses. The next major checkpoint for these evaluations will be the continued release of findings from the UK COVID-19 Inquiry, which aims to provide a transparent account of the clinical decisions made during the crisis.
We invite you to share this article to help combat medical misinformation and welcome your thoughts in the comments below.
